Article thumbnail

Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study

By Kathryn P. Burdon, Megan E. Rudock, Allison B. Lehtinen, Carl D. Langefeld, Donald W. Bowden, Thomas C. Register, Yongmei Liu, Barry I. Freedman, J. Jeffrey Carr, Catherine C. Hedrick and Stephen S. Rich


Aims. Genes of the 5-lipoxygenase pathway are compelling candidates for atherosclerosis. We hypothesize that polymorphisms in ALOX12, ALOX15, ALOX5, and ALOX5AP genes are associated with subclinical atherosclerosis in multiple vascular beds. Methods. Families with two or more siblings with type 2 diabetes and their nondiabetic siblings were studied as part of the Diabetes Heart Study (DHS). European American diabetic (n = 828) and nondiabetic (n = 170) siblings were genotyped for SNPs in the ALOX12, ALOX15, ALOX5, and ALOX5AP genes. Subclinical measures of atherosclerosis (IMT, coronary (CorCP), carotid (CarCP) and aortic (AorCP) calcified plaque) were obtained. Results. Associations were observed between ALOX12 with CorCP, ALOX5 with CorCP, AorCP, and IMT, and ALOX5AP with CorCP and CarCP, independent of known epidemiologic risk factors. Further, lipoxygenase pathway SNPs that were associated with measures of atherosclerosis were associated with markers of inflammation (CRP, ICAM-1) and calcification (MGP). Conclusions. Polymorphisms within ALOX12, ALOX5, and ALOX5AP are genetically associated with subclinical atherosclerosis and with biomarkers of disease in families with type 2 diabetes. These results suggest that variants in lipoxygenase pathway genes may have pleiotropic effects on multiple components that determine risk of cardiovascular disease

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). 12/15-lipoxygenase activity mediates inflammatory monocyte/ endothelial interactions and atherosclerosis in vivo,”
  2. (2001). 12/15-lipoxygenase gene disruption attenuates atherogenesis
  3. (2006). A variant of the gene encoding leukotriene
  4. (2001). Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice,”
  5. (2005). Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor
  6. (2005). Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population,”
  7. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime,”
  8. (2002). Autosomal genome-wide scan for coronary artery calcification loci in sibshipsathighriskforhypertension,”Arteriosclerosis,Thrombosis,
  9. (1989). Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,” The New England
  10. (2005). Calcified coronary artery plaque measurement with cardiac CT in populationbased studies: standardized protocol of
  11. (1990). Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophagerich areas of atherosclerotic lesions,”
  12. (2004). D w y e r ,H .A l l a y e e ,K .M .D w y e r ,e ta l . ,“ A r a c h i d o n a t e 5-lipoxygenase promoter genotype, dietary arachidonic acid,
  13. (1999). Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo Edeficient mice,”
  14. (2005). Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomizedtrial,”JournaloftheAmericanMedicalAssociation,
  15. (2002). Evidence for heritability of abdominal aortic calcific deposits in the Framingham Heart
  16. (2003). Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis,”
  17. (2001). Familial aggregation of coronary artery calcium
  18. (2000). G.Gaeta,M.DeMichele,S.Cuomo,etal.,“Arterialabnormalities in the offspring of patients with premature myocardial infarction,” The New England
  19. (1996). Genetic basis of variation in carotid artery wall thickness,”
  20. (2002). h a o ,C .A .C u ff,
  21. (2005). Heritability of carotid artery atherosclerotic lesions: an ultrasound study
  22. (2002). Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent,”
  23. (1989). Human genetics and coronary heart disease: a public health perspective,”
  24. (2002). Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility
  25. (2003). Increased production of 12/15 lipoxygenase eicosanoids accelerates monocyte/endothelial interactions in diabetic db/db mice,”
  26. (2002). Inflammation in atherosclerosis,”
  27. (2002). L.A.Lange,D.W.Bowden,C.D.Langefeld,etal.,“Heritability of carotid artery intima-medial thickness in type 2 diabetes,”
  28. (2005). Leukotriene B4 signaling through NF-κBdependent BLT 1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia,”
  29. (2005). Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution,”
  30. (2001). Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model,”
  31. (1986). Longitudinal data analysis for discrete and continuous outcomes,”
  32. (2001). M.Mehrabian,J.Wong,X.Wang,etal.,“Geneticlocusinmice that blocks development of atherosclerosis despite extreme hyperlipidemia,”
  33. (1996). Macrophagemediated 15-lipoxygenase expression protects against atherosclerosis development,”
  34. (1992). Mammalian lipoxygenases: molecular structures and functions,”
  35. (2006). Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification,”
  36. Mechanisms in antiinflammation and resolution: the role of lipoxins and aspirintriggered lipoxins,”
  37. (2000). Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis
  38. (2003). Pedigree disequilibrium tests for multilocus haplotypes,”
  39. (2001). Prostaglandins and leukotrienes: advances in eicosanoidbiology,”Science,vol.294,no.5548,pp.1871–1875,
  40. (2004). Racespecific relationships between coronary and carotid artery calcification and carotid intimal medial thickness,”
  41. (2003). Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators,”
  42. (1997). Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice,”
  43. (2005). The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis,”
  44. (2004). The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke,”
  45. (2004). Thematic review series: the pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis,”